Literature DB >> 33269023

The impact of obesity to antioxidant defense parameters in adolescents with increased cardiovascular risk.

Emina Čolak1, Dragana Pap2, Ljubinka Nikolić3, Sanja Vicković4.   

Abstract

BACKGROUND: The goal of this study was to assess the oxidative stress status through the values of antioxidant defense parameters: superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR) and total antioxidant status (TAS), as well as cardiovascular risk factors (total cholesterol, LDL-cholesterol, VLDL-cholesterol, non-HDL-cholesterol and triglycerides), anthropometric parameters (Body mass index-BMI, waist circumference-WC, hipp circumferemce-HC, waist-to-hipp ratio-WHR and inflammatory markers (high sensitive C-reactive protein) in a group of obese adolescents.
METHODS: A total of 238 students of both sexes, age of 22.32 ± 1.85 yr. were included in the study. According to the values of BMI lower and higher than 25 kg/m2 and WC higher and lower than 94 cm (males)/80 cm (females) the tested group of students was divided into 2 subgroups: Group 1 (increased risk for CVD) and Group 2 (lower risk for CVD).
RESULTS: Significantly reduced SOD and GPx with increased GR, TAS, inflammatory and lipoprotein parameters were obtained in Group 1 compared to Group 2. Significant positive association of hsCRP (OR:1.41; 95%CI 1.08-1.83; P=0.007), TAS (OR:827.2; 95%CI 19.27-35498; P=0.007) and GR (OR:1.13; 95%CI 1.05-1.21; P=0.002) and negative association of GPx (OR:0.97; 95%CI 0.94-1.003; P=0.043) and HDL-cholesterol (OR:0.41; 95%CI 0.176-0.963; P=0.0014) with cardiovascular risk factors were found in obese students. According to the ROC analysis GR>44.8 U/L, TAS>1.35 mmol/L, hsCRP>1.71 mg/L and HDL-cholesterol <1.13 mmol/L have sufficient predictive ability for cardiovascular disease in obese students.
CONCLUSIONS: Significant association of antioxidant defense parameters with anthropometric, lipid and inflammatory markers in obese students with increased cardiovascular risk suggest that screening of these parameters is necessary and highly recommended. 2020 Emina Čolak, Dragana Pap, Ljubinka Nikolić, Sanja Vicković, published by CEON/CEES.

Entities:  

Keywords:  antioxidant defense; cardiovascular risk factors; inflammation; obesity; oxidative stress

Year:  2020        PMID: 33269023      PMCID: PMC7682846          DOI: 10.2478/jomb-2019-0051

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   3.402


  37 in total

1.  Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans.

Authors:  S O Olusi
Journal:  Int J Obes Relat Metab Disord       Date:  2002-09

Review 2.  Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction.

Authors:  Matthias Barton; Oliver Baretella; Matthias R Meyer
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Growth, obesity, and cardiac structures in early childhood: the Generation R Study.

Authors:  Layla L de Jonge; Lennie van Osch-Gevers; Sten P Willemsen; Eric A P Steegers; Albert Hofman; Willem A Helbing; Vincent W V Jaddoe
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

4.  Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes.

Authors:  Masayoshi Higuchi; Gregory J Dusting; Hitesh Peshavariya; Fan Jiang; Sarah Tzu-Feng Hsiao; Elsa C Chan; Guei-Sheung Liu
Journal:  Stem Cells Dev       Date:  2012-11-12       Impact factor: 3.272

5.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

Authors:  N J Miller; C Rice-Evans; M J Davies; V Gopinathan; A Milner
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

6.  Oxidative stress in severely obese persons is greater in those with insulin resistance.

Authors:  Francisco J Tinahones; Mora Murri-Pierri; Lourdes Garrido-Sánchez; Jose M García-Almeida; Sara García-Serrano; Juan García-Arnés; Eduardo García-Fuentes
Journal:  Obesity (Silver Spring)       Date:  2008-11-20       Impact factor: 5.002

7.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants.

Authors:  Mariel M Finucane; Gretchen A Stevens; Melanie J Cowan; Goodarz Danaei; John K Lin; Christopher J Paciorek; Gitanjali M Singh; Hialy R Gutierrez; Yuan Lu; Adil N Bahalim; Farshad Farzadfar; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

8.  Mechanisms of endothelial dysfunction in obesity-associated hypertension.

Authors:  N S Lobato; F P Filgueira; E H Akamine; R C Tostes; M H C Carvalho; Z B Fortes
Journal:  Braz J Med Biol Res       Date:  2012-04-12       Impact factor: 2.590

Review 9.  Obesity-associated oxidative stress: strategies finalized to improve redox state.

Authors:  Isabella Savini; Maria Valeria Catani; Daniela Evangelista; Valeria Gasperi; Luciana Avigliano
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

10.  Body Mass Index and C-reactive Protein Are Potential Predictors of Asthma Development in Egyptian Polycystic Ovary Syndrome Patients.

Authors:  Hebatallah Ahmed Nasser; Nermeen Zakaria Abuel Ezz; Heidi Mohamed Abdel-Mageed; Rasha Ali Radwan
Journal:  J Med Biochem       Date:  2019-03-26       Impact factor: 3.402

View more
  9 in total

1.  Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus - a review article.

Authors:  Aleksandra Klisic; Irena Radoman Vujacic; Jelena Munjas; Ana Ninic; Jelena Kotur-Stevuljevic
Journal:  Arch Med Sci       Date:  2022-04-10       Impact factor: 3.707

2.  ANOM Approach for Statistical Evaluation of Some Antioxidant Enzyme Activities.

Authors:  Canan Demir; Sıddık Keskin; Fatih Şen
Journal:  Front Chem       Date:  2022-05-26       Impact factor: 5.545

3.  One-lung ventilation patients: Clinical context of administration of different doses of dexmedetomidine.

Authors:  Hui Jiang; Yu Kang; Chunlin Ge; Zhenying Zhang; Yan Xie
Journal:  J Med Biochem       Date:  2022-04-08       Impact factor: 2.157

4.  Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Ana Ninic; Jelena Kotur-Stevuljevic
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

5.  Can we reduce oxidative stress with liver transplantation?

Authors:  Mesut Aydin; Yaren Dirik; Canan Demir; Harun Egemen Tolunay; Halit Demir
Journal:  J Med Biochem       Date:  2021-09-03       Impact factor: 3.402

6.  Preclinical insights into fucoidan as a nutraceutical compound against perfluorooctanoic acid-associated obesity via targeting endoplasmic reticulum stress.

Authors:  Jiaqi Liu; Chao Guo; Yuqin Wang; Min Su; Wenjun Huang; Keng Po Lai
Journal:  Front Nutr       Date:  2022-08-12

7.  A relation of serum homocysteine and uric acid in Bosnian diabetic patients with acute myocardial infarction.

Authors:  Marijana Marković-Boras; Adlija Čaušević; Marina Ćurlin
Journal:  J Med Biochem       Date:  2021-06-05       Impact factor: 3.402

8.  Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI).

Authors:  Nesim Aladağ; Ramazan Asoğlu; Mahmut Ozdemir; Emin Asoğlu; Atabey Rukiye Derin; Canan Demir; Halit Demir
Journal:  J Med Biochem       Date:  2021-06-05       Impact factor: 3.402

9.  Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Sanja Vujcic; Vesna Spasojevic-Kalimanovska; Jelena Kotur-Stevuljevic; Ana Ninic
Journal:  Oxid Med Cell Longev       Date:  2021-01-27       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.